Home » Topics » BioWorld Science

BioWorld Science
RSS

Immuron reports data from TREAT-003 study of IMM-124-E in severe alcoholic hepatitis

Aug. 9, 2019

TaiGen Biotechnology presents influenza cap-dependent endonuclease inhibitors

Aug. 9, 2019

Kala Pharmaceuticals receives FDA complete response letter for KPI-121 0.25%

Aug. 9, 2019

First patient dosed in phase Ib/IIa PREVAIL study of PRV-3279

Aug. 9, 2019

DPS-2: A dual MEK/ERK and PI3K/AKT inhibitor developed for colorectal cancer

Aug. 9, 2019

89bio initiates phase Ib/IIa study of BIO89-100 for the treatment of NASH

Aug. 9, 2019

ZL-0580: a novel BRD4-selective small molecule that suppresses HIV

Aug. 9, 2019

APOC1 as a novel diagnostic and prognostic biomarker for gastric cancer

Aug. 9, 2019

Elicio presents preclinical data for ELI-002 vaccine targeting KRAS-driven cancers

Aug. 9, 2019

Novel M4 positive allosteric modulator with improved physicochemical properties and favorable PK

Aug. 9, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...